These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17283171)

  • 1. Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.
    Du Y; Honeychurch J; Glennie M; Johnson P; Illidge T
    Cancer Res; 2007 Feb; 67(3):1335-43. PubMed ID: 17283171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
    Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.
    Michel RB; Rosario AV; Andrews PM; Goldenberg DM; Mattes MJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):777-86. PubMed ID: 15701868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
    J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of CD22-expressing Daudi tumors in nude mice with a 90Y-labeled anti-CD22 monoclonal antibody.
    Vallera DA; Brechbiel MW; Burns LJ; Panoskaltsis-Mortari A; Dusenbery KE; Clohisy DR; Vitetta ES
    Clin Cancer Res; 2005 Nov; 11(21):7920-8. PubMed ID: 16278417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
    Lin Y; Pagel JM; Axworthy D; Pantelias A; Hedin N; Press OW
    Cancer Res; 2006 Apr; 66(7):3884-92. PubMed ID: 16585217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy.
    Du Y; Honeychurch J; Cragg MS; Bayne M; Glennie MJ; Johnson PW; Illidge TM
    Blood; 2004 Feb; 103(4):1485-94. PubMed ID: 14576070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.
    Tutt AL; French RR; Illidge TM; Honeychurch J; McBride HM; Penfold CA; Fearon DT; Parkhouse RM; Klaus GG; Glennie MJ
    J Immunol; 1998 Sep; 161(6):3176-85. PubMed ID: 9743386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.
    Illidge T; Honeychurch J; Vandersteen A; Cragg M
    Cancer Biother Radiopharm; 2000 Dec; 15(6):581-91. PubMed ID: 11190490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell cytotoxicity with radiolabeled antibodies.
    Ong GL; Elsamra SE; Goldenberg DM; Mattes MJ
    Clin Cancer Res; 2001 Jan; 7(1):192-201. PubMed ID: 11205908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.
    Michel RB; Brechbiel MW; Mattes MJ
    J Nucl Med; 2003 Apr; 44(4):632-40. PubMed ID: 12679410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas.
    Peterson JA; Blank EW; Ceriani RL
    Cancer Res; 1997 Mar; 57(6):1103-8. PubMed ID: 9067279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate.
    Berndorff D; Borkowski S; Sieger S; Rother A; Friebe M; Viti F; Hilger CS; Cyr JE; Dinkelborg LM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7053s-7063s. PubMed ID: 16203802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas.
    Lindén O; Tennvall J; Cavallin-Ståhl E; Darte L; Garkavij M; Lindner KJ; Ljungberg M; Ohlsson T; Sjögreen K; Wingårdh K; Strand SE
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3287s-3291s. PubMed ID: 10541377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy of malignancies.
    Reilly RM
    Clin Pharm; 1991 May; 10(5):359-75. PubMed ID: 2049898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the antitumor effect of radiolabeled monoclonal antibodies.
    Knox SJ; Levy R; Miller RA; Uhland W; Schiele J; Ruehl W; Finston R; Day-Lollini P; Goris ML
    Cancer Res; 1990 Aug; 50(16):4935-40. PubMed ID: 2379158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma.
    Bridges SH; Kruisbeek AM; Longo DL
    J Immunol; 1987 Dec; 139(12):4242-9. PubMed ID: 3500981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretargeted radioimmunotherapy for B-cell lymphomas.
    Green DJ; Pagel JM; Pantelias A; Hedin N; Lin Y; Wilbur DS; Gopal A; Hamlin DK; Press OW
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5598s-5603s. PubMed ID: 17875795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.